Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 2/2014

Open Access 01-04-2014 | Research article

N-myc downstream-regulated gene 2 expression is associated with glucose transport and correlated with prognosis in breast carcinoma

Authors: Ji Ma, Wenchao Liu, Hang Guo, Shaoqing Li, Wei Cao, Xilin Du, Shixiong Lei, Wugang Hou, Lize Xiong, Libo Yao, Nanlin Li, Yan Li

Published in: Breast Cancer Research | Issue 2/2014

Login to get access

Abstract

Introduction

N-myc downstream-regulated gene 2 (NDRG2), a novel tumour suppressor and cell stress-related gene, is involved in many cell metabolic processes, such as hormone, ion and fluid metabolism. We investigated whether NDRG2 is involved in any glucose-dependent energy metabolism, as well as the nature of its correlation with breast carcinoma.

Methods

The correlations between NDRG2 expression and glucose transporter 1 (GLUT1) expression in clinical breast carcinoma tissues were analysed. The effects of NDRG2 on glucose uptake were assessed in breast cancer cells and xenograft tumours. The consequences of NDRG2-induced regulation of GLUT1 at the transcription and translation levels and the interaction between NDRG2 and GLUT1 were examined.

Results

Data derived from clinical breast carcinoma specimens revealed that (1) patients with high NDRG2 expression had better disease-free survival and overall survival than those with low NDRG2 expression and (2) NDRG2 expression was negatively correlated with GLUT1 expression in these breast carcinoma tissues. NDRG2 inhibited glucose uptake by promoting GLUT1 protein degradation without affecting GLUT1 transcription in both breast cancer cells and xenograft tumours. In addition, NDRG2 protein interacted and partly colocalised with GLUT1 protein in cell cytoplasm areas.

Conclusions

The results of our study support the notion that NDRG2 plays an important role in tumour glucose metabolism, in which GLUT1 is a likely candidate contributor to glucose uptake suppression and tumour growth. Targeting the actions of NDRG2 in cell glucose-dependent energy delivery may provide an attractive strategy for therapeutic intervention in human breast carcinoma.
Appendix
Available only for authorised users
Literature
1.
Yao L, Zhang J, Liu X: NDRG2: a Myc-repressed gene involved in cancer and cell stress. Acta Biochim Biophys Sin (Shanghai). 2008, 40: 625-635. 10.1111/j.1745-7270.2008.00434.x.CrossRef
2.
Deng Y, Yao L, Chau L, Ng SS, Peng Y, Liu X, Au WS, Wang J, Li F, Ji S, Han H, Nie X, Li Q, Kung HF, Leung SY, Lin MC: N-Myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation. Int J Cancer. 2003, 106: 342-347. 10.1002/ijc.11228.CrossRefPubMed
3.
Liu J, Yang L, Zhang J, Zhang J, Chen Y, Li K, Li Y, Li Y, Yao L, Guo G: Knock-down of NDRG2 sensitizes cervical cancer HeLa cells to cisplatin through suppressing Bcl-2 expression. BMC Cancer. 2012, 12: 370-10.1186/1471-2407-12-370.CrossRefPubMedPubMedCentral
4.
Liu N, Wang L, Li X, Yang Q, Liu X, Zhang J, Zhang J, Wu Y, Ji S, Zhang Y, Yan A, Han H, Yao L: N-Myc downstream-regulated gene 2 is involved in p53-mediated apoptosis. Nucleic Acids Res. 2008, 36: 5335-5349. 10.1093/nar/gkn504.CrossRefPubMedPubMedCentral
5.
Ma J, Liu W, Yan X, Wang Q, Zhao Q, Xue Y, Ren H, Wu L, Cheng Y, Li S, Miao L, Yao L, Zhang J: Inhibition of endothelial cell proliferation and tumor angiogenesis by up-regulating NDRG2 expression in breast cancer cells. PloS One. 2012, 7: e32368-10.1371/journal.pone.0032368.CrossRefPubMedPubMedCentral
6.
Oh S, Kim D, Kim DH, Chang HH, Sohn KC, Kim KH, Jung SH, Lee BK, Kim JH, Kim KD: NDRG2 correlated with favorable recurrence-free survival inhibits metastasis of mouse breast cancer cells via attenuation of active TGF-β production. Carcinogenesis. 2012, 33: 1882-1888. 10.1093/carcin/bgs211.CrossRefPubMed
7.
Nichols NR: Ndrg2, a novel gene regulated by adrenal steroids and antidepressants, is highly expressed in astrocytes. Ann N Y Acad Sci. 2003, 1007: 349-356. 10.1196/annals.1286.034.CrossRefPubMed
8.
Foletta VC, Prior MJ, Stupka N, Carey K, Segal DH, Jones S, Swinton C, Martin S, Cameron-Smith D, Walder KR: NDRG2, a novel regulator of myoblast proliferation, is regulated by anabolic and catabolic factors. J Physiol. 2009, 587: 1619-1634. 10.1113/jphysiol.2008.167882.CrossRefPubMedPubMedCentral
9.
Takahashi K, Saitoh A, Yamada M, Iwai T, Inagaki M, Yamada M: Dexamethasone indirectly induces Ndrg2 expression in rat astrocytes. J Neurosci Res. 2012, 90: 160-166. 10.1002/jnr.22727.CrossRefPubMed
10.
Burchfield JG, Lennard AJ, Narasimhan S, Hughes WE, Wasinger VC, Corthals GL, Okuda T, Kondoh H, Biden TJ, Schmitz-Peiffer C: Akt mediates insulin-stimulated phosphorylation of Ndrg2: evidence for cross-talk with protein kinase Cθ. J Biol Chem. 2004, 279: 18623-18632.CrossRefPubMed
11.
Shen L, Liu X, Hou W, Yang G, Wu Y, Zhang R, Li X, Che H, Lu Z, Zhang Y, Liu X, Yao L: NDRG2 is highly expressed in pancreatic β cells and involved in protection against lipotoxicity. Cell Mol Life Sci. 2010, 67: 1371-1381. 10.1007/s00018-010-0258-1.CrossRefPubMed
12.
Sun Z, Tong G, Ma N, Li J, Li X, Li S, Zhou J, Xiong L, Cao F, Yao L, Wang H, Shen L: NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia–reperfusion injury. Basic Res Cardiol. 2013, 108: 341-CrossRefPubMed
13.
Boulkroun S, Le Moellic C, Blot-Chabaud M, Farman N, Courtois-Coutry N: Expression of androgen receptor and androgen regulation of NDRG2 in the rat renal collecting duct. Pflugers Arch. 2005, 451: 388-394. 10.1007/s00424-005-1410-x.CrossRefPubMed
14.
Li Y, Yang J, Li S, Zhang J, Zheng J, Hou W, Zhao H, Guo Y, Liu X, Dou K, Situ Z, Yao L: N-myc downstream-regulated gene 2, a novel estrogen-targeted gene, is involved in the regulation of Na+/K+-ATPase. J Biol Chem. 2011, 286: 32289-32299.CrossRefPubMedPubMedCentral
15.
Boulkroun S, Fay M, Zennaro MC, Escoubet B, Jaisser F, Blot-Chabaud M, Farman N, Courtois-Coutry N: Characterization of rat NDRG2 (N-Myc downstream regulated gene 2), a novel early mineralocorticoid-specific induced gene. J Biol Chem. 2002, 277: 31506-31515.CrossRefPubMed
16.
Murray JT, Campbell DG, Morrice N, Auld GC, Shpiro N, Marquez R, Peggie M, Bain J, Bloomberg GB, Grahammer F, Lang F, Wulff P, Kuhl D, Cohen P: Exploitation of KESTREL to identify NDRG family members as physiological substrates for SGK1 and GSK3. Biochem J. 2004, 384: 477-488. 10.1042/BJ20041057.CrossRefPubMedPubMedCentral
17.
Wielpütz MO, Lee IH, Dinudom A, Boulkroun S, Farman N, Cook DI, Korbmacher C, Rauh R: (NDRG2) stimulates amiloride-sensitive Na+ currents in Xenopus laevis oocytes and Fisher rat thyroid cells. J Biol Chem. 2007, 282: 28264-28273.CrossRefPubMed
18.
Medina RA, Owen GI: Glucose transporters: expression, regulation and cancer. Biol Res. 2002, 35: 9-26.CrossRefPubMed
19.
20.
21.
Augustin R: The protein family of glucose transport facilitators: it’s not only about glucose after all. IUBMB Life. 2010, 62: 315-333.PubMed
22.
Adekola K, Rosen ST, Shanmugam M: Glucose transporters in cancer metabolism. Curr Opin Oncol. 2012, 24: 650-654. 10.1097/CCO.0b013e328356da72.CrossRefPubMed
23.
Carvalho KC, Cunha IW, Rocha RM, Ayala FR, Cajaíba MM, Begnami MD, Vilela RS, Paiva GR, Andrade RG, Soares FA: GLUT1 expression in malignant tumors and its use as an immunodiagnostic marker. Clinics (Sao Paulo). 2011, 66: 965-972. 10.1590/S1807-59322011000600008.CrossRef
24.
Chan DA, Sutphin PD, Nguyen P, Turcotte S, Lai EW, Banh A, Reynolds GE, Chi JT, Wu J, Solow-Cordero DE, Bonnet M, Flanagan JU, Bouley DM, Graves EE, Denny WA, Hay MP, Giaccia AJ: Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality. Sci Transl Med. 2011, 3: 94ra70-PubMedPubMedCentral
25.
Amann T, Hellerbrand C: GLUT1 as a therapeutic target in hepatocellular carcinoma. Expert Opin Ther Targets. 2009, 13: 1411-1427. 10.1517/14728220903307509.CrossRefPubMed
26.
Basturk O, Singh R, Kaygusuz E, Balci S, Dursun N, Culhaci N, Adsay NV: GLUT-1 expression in pancreatic neoplasia: implications in pathogenesis, diagnosis, and prognosis. Pancreas. 2011, 40: 187-192. 10.1097/MPA.0b013e318201c935.CrossRefPubMedPubMedCentral
27.
Shen L, Sun X, Fu Z, Yang G, Li J, Yao L: The fundamental role of the p53 pathway in tumor metabolism and its implication in tumor therapy. Clin Cancer Res. 2012, 18: 1561-1567. 10.1158/1078-0432.CCR-11-3040.CrossRefPubMed
28.
Zheng J, Liu Q, Li Y, Yang J, Ma J, Yu F, Shi H, Ren Q, Zhang R, Zhang J, Xue Y, Tao Y, Jiang N, Guo H, Yao L, Liu W: NDRG2 expression regulates CD24 and metastatic potential of breast cancer cells. Asian Pac J Cancer Prev. 1817–1821, 2010: 11-
29.
Shon SK, Kim A, Kim JY, Kim KI, Yang Y, Lim JS: Bone morphogenetic protein-4 induced by NDRG2 expression inhibits MMP-9 activity in breast cancer cells. Biochem Biophys Res Commun. 2009, 385: 198-203. 10.1016/j.bbrc.2009.05.038.CrossRefPubMed
30.
Park Y, Shon SK, Kim A, Kim KI, Yang Y, Cho DH, Lee MS, Lim JS: SOCS1 induced by NDRG2 expression negatively regulates STAT3 activation in breast cancer cells. Biochem Biophys Res Commun. 2007, 363: 361-367. 10.1016/j.bbrc.2007.08.195.CrossRefPubMed
31.
Liu N, Wang L, Liu X, Yang Q, Zhang J, Zhang W, Wu Y, Shen L, Zhang Y, Yang A, Han H, Zhang J, Yao L: Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines. Biochem Biophys Res Commun. 2007, 358: 164-169. 10.1016/j.bbrc.2007.04.089.CrossRefPubMed
32.
Lorentzen A, Lewinsky RH, Bornholdt J, Vogel LK, Mitchelmore C: Expression profile of the N-myc downstream regulated gene 2 (NDRG2) in human cancers with focus on breast cancer. BMC Cancer. 2011, 11: 14-10.1186/1471-2407-11-14.CrossRefPubMedPubMedCentral
33.
Schwartzenberg-Bar-Yoseph F, Armoni M, Karnieli E: The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res. 2004, 64: 2627-2633. 10.1158/0008-5472.CAN-03-0846.CrossRefPubMed
34.
Kawauchi K, Araki K, Tobiume K, Tanaka N: p53 regulates glucose metabolism through an IKK-NF-κB pathway and inhibits cell transformation. Nat Cell Biol. 2008, 10: 611-618. 10.1038/ncb1724.CrossRefPubMed
35.
Zhang J, Li F, Liu X, Shen L, Liu J, Su J, Zhang W, Deng Y, Wang L, Liu N, Han W, Zhang J, Ji S, Yang A, Han H, Yao L: The repression of human differentiation-related gene NDRG2 expression by Myc via Miz-1-dependent interaction with the NDRG2 core promoter. J Biol Chem. 2006, 281: 39159-39168.CrossRefPubMed
36.
Wang L, Liu N, Yao L, Li F, Zhang J, Deng Y, Liu J, Ji S, Yang A, Han H, Zhang Y, Zhang J, Han W, Liu X: NDRG2 is a new HIF-1 target gene necessary for hypoxia-induced apoptosis in A549 cells. Cell Physiol Biochem. 2008, 21: 239-250. 10.1159/000113765.CrossRefPubMed
37.
Osthus RC, Shim H, Kim S, Li Q, Reddy R, Mukherjee M, Xu Y, Wonsey D, Lee LA, Dang CV: Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. J Biol Chem. 2000, 275: 21797-21800.CrossRefPubMed
38.
Chung FY, Huang MY, Yeh CS, Chang HJ, Cheng TL, Yen LC, Wang JY, Lin SR: GLUT1 gene is a potential hypoxic marker in colorectal cancer patients. BMC Cancer. 2009, 9: 241-10.1186/1471-2407-9-241.CrossRefPubMedPubMedCentral
39.
Zhang J, Liu J, Li X, Li F, Wang L, Zhang J, Liu X, Shen L, Liu N, Deng Y, Yang A, Han H, Zhao M, Yao L: The physical and functional interaction of NDRG2 with MSP58 in cells. Biochem Biophys Res Commun. 2007, 352: 6-11. 10.1016/j.bbrc.2006.10.141.CrossRefPubMed
40.
Qu X, Zhai Y, Wei H, Zhang C, Xing G, Yu Y, He F: Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family. Mol Cell Biochem. 2002, 229: 35-44. 10.1023/A:1017934810825.CrossRefPubMed
Metadata
Title
N-myc downstream-regulated gene 2 expression is associated with glucose transport and correlated with prognosis in breast carcinoma
Authors
Ji Ma
Wenchao Liu
Hang Guo
Shaoqing Li
Wei Cao
Xilin Du
Shixiong Lei
Wugang Hou
Lize Xiong
Libo Yao
Nanlin Li
Yan Li
Publication date
01-04-2014
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 2/2014
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr3628

Other articles of this Issue 2/2014

Breast Cancer Research 2/2014 Go to the issue

Research article

Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways

Review

Maternal exposure to diethylstilbestrol during pregnancy and increased breast cancer risk in daughters

Review

Retinoblastoma tumor suppressor pathway in breast cancer: prognosis, precision medicine, and therapeutic interventions

Research article

International study on inter-reader variability for circulating tumor cells in breast cancer

Research article

Identification of miR-26 as a key mediator of estrogen stimulated cell proliferation by targeting CHD1, GREB1 and KPNA2

Research article

Postpartum breast involution reveals regression of secretory lobules mediated by tissue-remodeling
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits